Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twice Weekly vs Daily Iron Therapy in Children With Cerebral Palsy
NCT06176430Phase 4Not yet recruiting
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
- Start
- Feb 2024
- Primary completion
- Mar 2024
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial of ferrous sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoint: Change in Hemoglobin levels from baseline at 4 weeks. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06176430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06176430.